Skip to content

Multi-domain intervention (YoCogDiPP) for patients with depression

The effect of multi-domain intervention (YoCogDiPP) on cognitive impairment, heart rate variability, cortisol, inflammatory markers and depression scores in patients with depression: randomized control trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079464
Enrollment
120
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F321- Major depressive disorder, singleepisode, moderate

Interventions

Intervention1: Multidomain Intervention: 45 min at least 5 times a week for 12 weeks. The intervention will consist of YoCogDiPP (which include 5 components namely Yoga Nidra, Cognitive Training, Diet

Sponsors

ICMR INDIAN COUNCIL OF MEDICAL RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-55 years both genders, Diagnosis according to ICD 10 (F32.xx and F33.xx except F32.3 and F33.3) by psychiatrist, HDRS score equal to or more than 8, ongoing treatment for atleast 4 weeks or more, normal or corrected to normal vision (6/6 according to Snellen chart), normal color vision assessed by ishihara chart.

Exclusion criteria

Exclusion criteria: Any history brain secondary causes of cognitive impairment (like history of stroke, brain injury, exposure to toxins or neuroleptics, history of neurological disease, dementia, Alzheimer’s disease or any neurological illness with significant cognitive impairment). Dementia will be ruled out with MoCA score =18. Patients on any drugs other than antidepressants that can affect cardiac autonomic functions like antihistaminics, cough or cold medications, diuretics, sympathomimetics, parasympathomimetics will be excluded from the study. Any history of cardiac disease, allergy or non-acceptance of diet proposed

Design outcomes

Primary

MeasureTime frame
Improvement in cognitive, autonomic, inflammatory markers with reduction in depression scores.Timepoint: baseline and after 4, 8, and 12 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Ashlesh Patil

AIIMS Nagpur

dr.ashlesh.p@gmail.com9650344666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026